chevron_leftBack
As of 20 June 2026, Godavari Drugs Ltd. has a market cap of $10.08M USD, ranking #41265 globally and #3264 in India.
It ranks #3669 in the Healthcare sector, and #1196 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$10.08MUSD
951.86M INR
Enterprise Value
$17.67MUSD
1.67B INR
Revenue (TTM)
$10.46MUSD
986.94M INR
EBITDA (TTM)
$1.2MUSD
112.98M INR
Net Income (TTM)
$391.11KUSD
36.92M INR
EBITDA Margin
11%
Profit Margin
3.7%
PE Ratio
25.7
PS Ratio
1.0
PB Ratio
2.1
EV/EBITDA
14.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mukund Kakani
open_in_new
Employees
106
Founded
1987
Website
godavaridrugs.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 10% | -4.6% | 34% | 29% | 32% | 25% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
530317
(GODAVARI)
Godavari Drugs Ltd
ISIN: INE362C01012
Shares Out.:
Shares Outstanding:
10.127M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
126.40 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Godavari Drugs Ltd.
Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs Limited was incorporated in 1987 and is based in Secunderabad, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
448K%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
182K%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
150K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
116K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
98K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
96K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
8M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
5M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
4M%
|
97.4
|
|
SIX: RO
|
$318.3B
3M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
3M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
3M%
|
15.1
|
chevron_leftBack